These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

60 related articles for article (PubMed ID: 13696747)

  • 1. [The serological aspects of diffuse mesenchymal reactions].
    ENDERLIN M
    Schweiz Med Wochenschr; 1960 Sep; 90():1017-21. PubMed ID: 13696747
    [No Abstract]   [Full Text] [Related]  

  • 2. Systemic manifestations of rheumatoid arthritis (rheumatoid disease) accentuated by steroid therapy.
    PAUL WD
    J Iowa State Med Soc; 1961 Apr; 51():205-16. PubMed ID: 13733461
    [No Abstract]   [Full Text] [Related]  

  • 3. Serological reactions to polysaccharides in rheumatoid arthritis.
    GOFTON JP; THOMAS JW; ROBINSON HS
    Can Med Assoc J; 1957 Dec; 77(12):1098-102. PubMed ID: 13489605
    [No Abstract]   [Full Text] [Related]  

  • 4. [Serological reactions in rheumatism].
    TICHY H
    Z Rheumaforsch; 1957 Dec; 16(11-12):378-82. PubMed ID: 13531530
    [No Abstract]   [Full Text] [Related]  

  • 5. [Serological reactions in chronic rheumatic polyarthritis].
    DE SEZE S; HIOCO D; BADIN J; DEBEYRE N
    Acta Med Scand Suppl; 1958; 341():133-42. PubMed ID: 13605638
    [No Abstract]   [Full Text] [Related]  

  • 6. [Prognostic value of serological rheumatic reactions].
    MENDES DE LEON C; DE MENDES DE LEON
    Ned Tijdschr Geneeskd; 1959 May; 103(18):984-5. PubMed ID: 13657253
    [No Abstract]   [Full Text] [Related]  

  • 7. [The new serological markers of rheumatoid arthritis].
    Tuchocka-Piotrowska A; Puszczewicz M
    Pol Merkur Lekarski; 2007 Sep; 23(135):215-20. PubMed ID: 18080699
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Serologic reactions seen in rheumatoid arthritis.
    RAGAN C; CHRISTIAN CL
    Trans Am Clin Climatol Assoc; 1957-1958; 69():1-8. PubMed ID: 13581082
    [No Abstract]   [Full Text] [Related]  

  • 9. [Usefulness of anti-citrullinated protein antibodies in the diagnosis and prognosis of rheumatoid arthritis].
    Bas S
    Rev Med Suisse; 2005 Mar; 1(10):674, 677-8, 680 passim. PubMed ID: 15828370
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Peripheral ulcerative keratitis in rheumatoid arthritis: successful use of intravenous cyclophosphamide and comparison of clinical and serological characteristics.
    Clewes AR; Dawson JK; Kaye S; Bucknall RC
    Ann Rheum Dis; 2005 Jun; 64(6):961-2. PubMed ID: 15897315
    [No Abstract]   [Full Text] [Related]  

  • 11. Allogeneic mesenchymal stem cell and mesenchymal stem cell-differentiated chondrocyte suppress the responses of type II collagen-reactive T cells in rheumatoid arthritis.
    Zheng ZH; Li XY; Ding J; Jia JF; Zhu P
    Rheumatology (Oxford); 2008 Jan; 47(1):22-30. PubMed ID: 18077486
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Molecular aspects of rheumatoid arthritis: chemokines, environmental factors and transcription factors.
    Okamoto H
    FEBS J; 2008 Sep; 275(18):4447. PubMed ID: 18662306
    [No Abstract]   [Full Text] [Related]  

  • 13. [Various immunological aspects of diseases of autoaggression].
    GOLD E; FOTINO M
    Med Interna (Bucur); 1957 Jun; 9(6):829-40. PubMed ID: 13482667
    [No Abstract]   [Full Text] [Related]  

  • 14. Antibodies to citrullinated proteins in arthritis: pathology and promise.
    Klareskog L; Widhe M; Hermansson M; Rönnelid J
    Curr Opin Rheumatol; 2008 May; 20(3):300-5. PubMed ID: 18388522
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Additional diagnostic and clinical value of anti-cyclic citrullinated peptide antibodies compared with rheumatoid factor isotypes in rheumatoid arthritis.
    Vallbracht I; Helmke K
    Autoimmun Rev; 2005 Jul; 4(6):389-94. PubMed ID: 16081030
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The role of mesenchymal cells in the pathophysiology of inflammatory arthritis.
    Meyer LH; Franssen L; Pap T
    Best Pract Res Clin Rheumatol; 2006 Oct; 20(5):969-81. PubMed ID: 16980218
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Serological markers of viral infections in patients with rheumatoid arthritis].
    Kurbanov SA; Mamedov MK
    Georgian Med News; 2009 Jan; (166):65-7. PubMed ID: 19202223
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Systemic sclerosis-rheumatoid arthritis overlap syndrome: a unique combination of features suggests a distinct genetic, serological and clinical entity.
    Szücs G; Szekanecz Z; Zilahi E; Kapitány A; Baráth S; Szamosi S; Végvári A; Szabó Z; Szántó S; Czirják L; György Kiss C
    Rheumatology (Oxford); 2007 Jun; 46(6):989-93. PubMed ID: 17384178
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Proteomic: new advances in the diagnosis of rheumatoid arthritis.
    Tampoia M; Brescia V; Fontana A; Maggiolini P; Zucano A; Pansini N
    Clin Chim Acta; 2005 Jul; 357(2):219-25. PubMed ID: 15896730
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Improvement with rituximab in a patient with both rheumatoid arthritis and myasthenia gravis.
    Kerkeni S; Marotte H; Miossec P
    Muscle Nerve; 2008 Oct; 38(4):1343-5. PubMed ID: 18816604
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 3.